Nintedanib increases BCL-2 in fibrotic fibroblasts enhancing ABT-199 apoptosis and fibrosis resolution
{{output}}
Rationale: Progressive fibrosing interstitial lung diseases (PF-ILDs) have a large global impact and there is a pressing need to develop new therapies. Objectives... ...
